selection of treatment modalities for dementia related diseases
Amplicon Diagnostic Laboratory offers a service for analyzing genetic polymorphisms essential for determining the individual rate of metabolism of drugs used in alleviating symptoms and/or slowing the progression of dementia.
Our Service Includes:
- Precise analysis of genetic polymorphisms related to drug metabolism used in dementia therapy.
- Determining the individual rate of drug metabolism, which is crucial for the effectiveness of therapy.
- Interpretation of the obtained results, thereby providing information to enable the physician to tailor therapy to the individual needs of the patient.
Reduce the Risk - Your Personalized Path to Therapy
Metabolic Package
Pakiet Parkinson + Pakiet Alzheimer rozszerzony
€
240
00
-
Analysis of allelic variants of polymorphisms located in genes relevant for determining individual drug metabolism rate
-
ABCA1-06, CHAT-70, CHAT-90, CYP2C8-30, CYP2C8-80, CYP2C8-81, CYP2C9-10, CYP2C9-53, CYP2C19-60, CYP2D6-52, CYP2D6-55, CYP2D6-86, CYP3A4-74
Premium Pack
Pakiet 2 w 1 + Pakiet Metaboliczny
€
577
00
-
Analysis of allelic variants of polymorphisms located in genes influencing the risk of developing Parkinson's disease, Alzheimer's disease
-
as well as those significant for determining the individual rate of drug metabolism.
Top